Uncategorised - European Medical Journal

New Risk Stratification Model Developed for Patients Following Percutaneous Coronary Intervention

New Risk Stratification Model Developed for Patients Following Percutaneous Coronary Intervention

ACCURATE outcomes have been better predicted in ST-segment elevation myocardial infarction (STEMI) patients having undergone…

Lupus Panniculitis in Association with Anti-Phospholipid Antibody Syndrome on a Background of Systemic Lupus Erythematosus: A Case Report and Literature Review

Lupus panniculitis, also known as lupus profundus,1 is characterised by chronic and recurrent inflammatory lesions of subcutaneous tissue…

Innovation: Lessons Learned From a Surgical Neoteric's Perspective

In this webinar, Professor Jonathan Sackier shares his insights on innovation, looking at this from a surgeon’s perspective, and outlines the crucial differences between innovation and invention.

ICDS Interview with Dr Miklosh Bala

Dr Jonathan Sackier sat down with Dr Miklosh Bala to discuss, among other things, trauma surgery in the Israeli capital of Jerusalem.

The Illusion of Remission

Dr Raine described corticosteroids as the first IBD drugs to undergo clinical trials. A seminal study, one of the first to introduce the concept…

An interview with Prof Janneke van der Woude at UEG Week Barcelona 2019

We spoke to Prof Janneke van der Woude (UEG General Gastroenterology Representative) at UEG Week 2019…

Will α-Ketoglutarate Supplementation Pave a New Way for Colorectal Cancer Treatment?

Will α-Ketoglutarate Supplementation Pave a New Way for Colorectal Cancer Treatment?

COLORECTAL CANCER predominantly stems from a genetic mutation of APC. In general, a major proportion of people with the mutation…

COVID-19: What You Should Be Aware of As a Gastroenterologist and a Patient

COVID-19: What You Should Be Aware of As a Gastroenterologist and a Patient

COVID-19 has spread throughout the word and drastically affected everyday life and clinical practice. Although the disease…

Talking to Dr William Soliman

Dr William Soliman, Chairman and CEO, Accreditation Council for Medical Affairs, discusses establishing industry benchmarks, what it is like to join the field now, and what it means to be a futurist in medical affairs.

Predicting an Epidemic? Evolution Must be Considered

SCIENTISTS using mathematical models to predict the spread of disease across populations must consider evolutionary changes…